<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Systemic diseases associated with acquired perforating dermatoses</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Systemic diseases associated with acquired perforating dermatoses</h1>
<div class="graphic"><div class="figure"><div class="ttl">Systemic diseases associated with acquired perforating dermatoses</div><div class="cntnt"><table cellspacing="0"><tbody> <tr> <td> <ul> <li>Diabetes mellitus<sup>[1]</sup> </li> </ul> </td> </tr> <tr> <td> <ul> <li>Chronic renal insufficiency<sup>[1]</sup> </li> </ul> </td> </tr> <tr> <td> <ul> <li>Carcinoma </li> </ul> </td> </tr> <tr> <td class="indent1"> <ul style="list-style-type: disc;"> <li>Liver<sup>[2]</sup>, prostate<sup>[3]</sup>, Hodgkin's disease<sup>[4]</sup>, colon carcinoma<sup>[5]</sup>, leukemia<sup>[6]</sup>, nasopharyngeal carcinoma<sup>[7]</sup> </li> </ul> </td> </tr> <tr> <td> <ul> <li>Endocrine disease<sup>[8,9]</sup> </li> </ul> </td> </tr> <tr> <td class="indent1"> <ul style="list-style-type: disc;"> <li>Thyroid dysfunction </li> </ul> </td> </tr> <tr> <td class="indent1"> <ul style="list-style-type: disc;"> <li>Hyperparathyroidism </li> </ul> </td> </tr> <tr> <td> <ul> <li>Primary sclerosing cholangitis<sup>[10]</sup> </li> </ul> </td> </tr> <tr> <td> <ul> <li>AIDS<sup>[11]</sup> </li> </ul> </td> </tr> <tr> <td> <ul> <li>Pulmonary aspergillosis<sup>[12]</sup> </li> </ul> </td> </tr> <tr> <td> <ul> <li>Autoimmune disease </li> </ul> </td> </tr> <tr> <td class="indent1"> <ul style="list-style-type: disc;"> <li>Systemic lupus erythematosus<sup>[13]</sup> </li> </ul> </td> </tr> <tr> <td class="indent1"> <ul style="list-style-type: disc;"> <li>Dermatomyositis<sup>[14]</sup> </li> </ul> </td> </tr> <tr> <td> <ul> <li>Scabies<sup>[15-17]</sup> </li> </ul> </td> </tr> <tr> <td> <ul> <li>Poland syndrome<sup>[18]</sup> </li> </ul> </td> </tr> <tr> <td> <ul> <li>Hidradenitis suppurativa<sup>[19]</sup> </li> </ul> </td> </tr> </tbody></table></div><div class="graphic_reference">References: 

<ol>
<li>Kim SW, Kim MS, Lee JH, et al. A clinicopathologic study of thirty cases of acquired perforating dermatosis in Korea. Ann Dermatol 2014; 26:162.</li>
<li>Lee YS, Vijayasingam S, Tan YO, Wong ST. Acquired perforating dermatosis associated with recurrent hepatocellular carcinoma. Int J Dermatol 1996; 35:743.</li>
<li>Boeck K, Mempel M, Hein R, Ring J. Acquired perforating collagenosis in a patient with carcinoma of the prostate. Acta Derm Venereol 1997; 77:486.</li>
<li>Pedragosa R, Knobel HJ, Huguet P, et al. Reactive perforating collagenosis in Hodgkin's disease. Am J Dermatopathol 1987; 9:41.</li>
<li>Ruiz Villaverde R, Martin Sanchez MC, Blasco Melguizo J, Naranjo Sintes R. Reactive perforating collagenosis and colon carcinoma. Rev Clin Esp 2002; 202:298.</li>
<li>Karpouzis A, Tsatalas C, Sivridis E, et al. Acquired reactive perforating collagenosis associated with myelodysplastic syndrome evolving to acute myelogenous leukaemia. Australas J Dermatol 2004; 45:78.</li>
<li>Karpouzis A, Koukourakis MI, Sivridis E. Acquired reactive perforating collagenosis associated with nasopharynx carcinoma. J Eur Acad Dermatol Venereol 2004; 18 (Suppl. 1):62 (PS108).</li>
<li>Fatani MI, Al-Ghamdi YM, Al-Afif KA, et al. Acquired reactive perforating collagenosis associated with sick euthyroid syndrome. Saudi Med J 2002; 23:1408.</li>
<li>Faver IR, Daoud MS, Su WP. Acquired reactive perforating collagenosis. Report of six cases and review of the literature. J Am Acad Dermatol 1994; 30:575.</li>
<li>Skiba G, Milkiewicz P, Mutimer D, et al. Successful treatment of acquired perforating dermatosis with rifampicin in an Asian patient with sclerosing cholangitis. Liver 1999; 19:160.</li>
<li>Bank DE, Cohen PR, Kohn SR. Reactive perforating collagenosis in a setting of double disaster: acquired immunodeficiency syndrome and end-stage renal disease. J Am Acad Dermatol 1989; 21:371.</li>
<li>Kim JH, Kang WH. Acquired reactive perforating collagenosis in a diabetic patient with pulmonary aspergillosis. Cutis 2000; 66:425.</li>
<li>Ohashi T, Yamamoto T. Acquired reactive perforating collagenosis associated with systemic lupus erythematosus. J Dermatol 2016; 43:1097.</li>
<li>Amano H, Nagai Y, Kishi C, Ishikawa O. Acquired reactive perforating collagenosis in dermatomyositis. J Dermatol 2011; 38:1199.</li>
<li>Kurschat P, Kroger A, Scharffeter-Kochanek Y, Hunzelmann N. Acquired reactive perforating collagenosis triggered by scabies infection. Acta Derm Venereol 2000; 80:384.</li>
<li>Brinkmeier T, Herbst RA, Frosch PJ. Reactive perforating collagenosis associated with scabies in a diabetic. J Eur Acad Dermatol Venereol 2004; 18:588.</li>
<li>Hinrichs W, Breuckmann F, Altmeyer P, Kreuter A. Acquired perforating dermatosis: a report on 4 cases associated with scabies infection. J Am Acad Dermatol 2004; 51:665.</li>
<li>Fistarol SK, Itin PH. Acquired perforating dermatosis in a patient with Poland syndrome. Dermatology 2003; 207:390.</li>
<li>Babino G, Fulgione E, Russo T, et al. Kyrle disease associated with hidradenitis suppurativa successfully treated with tumour necrosis factor inhibition. J Eur Acad Dermatol Venereol 2020.</li></ol></div><div id="graphicVersion">Graphic 109809 Version 3.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
